5-Methoxy-6-methylpyrazin-2-amine

Catalog No.: 
ACDMSY442
CAS No.: 
1823918-18-8
Molecular Formula: 
C6H9N3O
Molecular Weight: 
139.16
5-Methoxy-6-methylpyrazin-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$285.00InquiryInquiry
1g95%$814.00InquiryInquiry
5g95%$4029.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Methoxy-6-methylpyrazin-2-amine
IUPAC Name5-methoxy-6-methylpyrazin-2-amine
MDL No.MFCD26521425
Molecular FormulaC6H9N3O
Molecular Weight139.16
SMILESNC1=NC(C)=C(OC)N=C1
InChI KeyQEGCSOBKXOSICI-UHFFFAOYSA-N
Synonym2-Pyrazinamine, 5-methoxy-6-methyl-;5-methoxy-6-methylpyrazin-2-amine
CAS No.1823918-18-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDMSY442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACEFOV697 route compound structure diagram
    ACEFOV697453548-87-3In Stock
  4. Then
  5. ACDMSY442 route product structure diagram
    ACDMSY4421823918-18-8
Inquiry

2. ACDMSY442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. ACEFOV697 route compound structure diagram
    ACEFOV697453548-87-3In Stock
  4. Then
  5. ACDMSY442 route product structure diagram
    ACDMSY4421823918-18-8
Inquiry

3. ACDMSY442 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDMSY442 route product structure diagram
    ACDMSY4421823918-18-8
Inquiry

Comments (0)